Sale!

EEF1A2 Gene Early infantile epileptic encephalopathy type 33 Genetic Test

4,400 د.إ

-21%

The EEF1A2 gene is associated with a rare neurological disorder known as early infantile epileptic encephalopathy type 33 (EIEE33). This condition is characterized by severe seizures that begin in infancy, often accompanied by developmental delays and various neurological challenges. The EEF1A2 gene plays a crucial role in protein synthesis within cells, and mutations in this gene can disrupt normal brain function, leading to the symptoms observed in EIEE33.

To diagnose this condition and potentially guide treatment options, genetic testing can be performed to identify mutations in the EEF1A2 gene. In the UAE, DNA Labs UAE offers a specific genetic test for the EEF1A2 gene, catering to families and individuals seeking answers about this rare epileptic disorder. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the EEF1A2 gene.

The cost of the EEF1A2 gene test at DNA Labs UAE is 4400 AED. This price includes the collection of the sample, the genetic analysis, and a comprehensive report that interprets the findings. This report can be an invaluable tool for healthcare providers in diagnosing EIEE33, understanding its severity, and potentially guiding treatment decisions. Families affected by early infantile epileptic encephalopathy or those with a history of the condition may consider this test to gain more insight into their medical situation and to inform their healthcare decisions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

EEF1A2 Gene Early Infantile Epileptic Encephalopathy Type 33 Genetic Test

Test Name: EEF1A2 Gene Early Infantile Epileptic Encephalopathy Type 33 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for EEF1A2 Gene Early Infantile Epileptic Encephalopathy Type 33 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EEF1A2 Gene Early Infantile Epileptic Encephalopathy Type 33.

Test Details: The EEF1A2 gene is associated with Early Infantile Epileptic Encephalopathy Type 33 (EIEE33), a rare genetic disorder characterized by seizures that begin in the first few months of life, developmental delays, and intellectual disability. NGS (Next Generation Sequencing) genetic testing can be used to analyze the EEF1A2 gene for mutations or changes that may be causing EIEE33. This test can help confirm a diagnosis of EIEE33 and provide information for genetic counseling and family planning. It is important to note that not all individuals with EIEE33 will have mutations in the EEF1A2 gene, and not all mutations in the gene will cause EIEE33. Therefore, genetic testing should be interpreted in conjunction with other clinical and diagnostic findings.

Test Name EEF1A2 Gene Early infantile epileptic encephalopathy type 33 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EEF1A2 Gene Early infantile epileptic encephalopathy type 33 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with EEF1A2 Gene Early infantile epileptic encephalopathy type 33
Test Details

The EEF1A2 gene is associated with Early Infantile Epileptic Encephalopathy Type 33 (EIEE33), a rare genetic disorder characterized by seizures that begin in the first few months of life, developmental delays, and intellectual disability.

NGS (Next Generation Sequencing) genetic testing can be used to analyze the EEF1A2 gene for mutations or changes that may be causing EIEE33. This test can help confirm a diagnosis of EIEE33 and provide information for genetic counseling and family planning.

It is important to note that not all individuals with EIEE33 will have mutations in the EEF1A2 gene, and not all mutations in the gene will cause EIEE33. Therefore, genetic testing should be interpreted in conjunction with other clinical and diagnostic findings.